CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Update

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the target of a significant increase in short interest in July. As of July 15th, there was short interest totaling 3,862 shares, an increase of 1,765.7% from the June 30th total of 207 shares. Based on an average daily trading volume, of 1,644 shares, the days-to-cover ratio is currently 2.3 days.

CSPC Pharmaceutical Group Stock Up 1.4%

Shares of CSPCY stock traded up C$0.06 during trading hours on Friday, reaching C$4.31. 463 shares of the company traded hands, compared to its average volume of 3,411. CSPC Pharmaceutical Group has a 12-month low of C$3.26 and a 12-month high of C$5.83. The firm has a 50-day moving average price of C$3.78 and a 200 day moving average price of C$4.40.

CSPC Pharmaceutical Group Company Profile

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.